Six out of 10 people in the UK trust pharma businesses to do what is right: up 1% on last year. The UK places more trust in pharma than European neighbours France (52%), Germany (55%), or the industry’s largest global market, the US (54%). Read More
Gene therapies could revolutionise the management of chronic cardiovascular diseases (CVDs) such as heart failure, according to GlobalData. The data and analytics company notes that there are currently 87* CVD gene therapies currently in development, and they hold potential to vastly improve patients’ quality of life. Fiona Chisholm, Pharma… Read More
UCB, a biopharmaceutical company, has presented new interim data from BE BRIGHT, an open-label extension (OLE) trial of an interleukin (IL)-17A/F inhibitor ‘bimekizumab’ for plaque psoriasis (PsO), at the 2021 American Academy of Dermatology (AAD) Summer Meeting. While the data are still preliminary, they strongly support a potential approval for… Read More
